SDHB germline variants are most notably associated with the highest morbidity and mortality, commonly developing extra-adrenal sympathetic paragangliomas with the greatest risk for metastatic disease (Andrews et al., 2018). This evidence concerns the gene SDHB and metastatic neoplasm.